Video Experimental Relacionado
Updated: Jun 11, 2026
12:27
The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice
Published on: April 3, 2014
Hipersensibilidad de las vías respiratorias a la histamina y mortalidad por enfermedad pulmonar obstructiva crónica:
J J Hospers1, D S Postma, B Rijcken
1Department of Epidemiology and Statistics, University of Groningen, The Netherlands.
Lancet (London, England)
|November 10, 2000
Resumen
El aumento de la hipersensibilidad de las vías respiratorias predice la mortalidad por enfermedad pulmonar obstructiva crónica (EPOC). Este riesgo está presente tanto en fumadores como en no fumadores, destacando un factor significativo en los resultados de salud respiratoria.
Área de la Ciencia:
- Medicina de las vías respiratorias.
- Epidemiología La epidemiología.
- Pulmonología Pulmonología.
Sus antecedentes:
- Fumar y la labilidad de las vías respiratorias son factores de riesgo establecidos para los síntomas respiratorios.
- Fumar también está relacionado con un aumento de la mortalidad.
- La relación entre la hipersensibilidad de las vías respiratorias, la mortalidad y el tabaquismo requiere más investigación.
Objetivo del estudio:
- Para determinar si la hipersensibilidad de las vías respiratorias está asociada con un aumento de la mortalidad.
- Evaluar si esta asociación es independiente del tabaquismo y la función pulmonar reducida.
Principales métodos:
- Un estudio de seguimiento de 30 años de habitantes de 2008 con datos de pruebas de desafío a la histamina.
- Datos recogidos de las comunidades de los Países Bajos (Vlagtwedde, Vlaardingen, Meppel).
- El análisis incluyó 1453 sobrevivientes y 526 muertes, con causas de muerte registradas.
Principales resultados:
- La mortalidad por enfermedad pulmonar obstructiva crónica (EPOC) aumentó significativamente con una mayor hipersensibilidad de las vías respiratorias.
- Los riesgos relativos para la mortalidad por EPOC aumentaron con los umbrales de histamina más bajos (por ejemplo, 15,8 para 1 g/L).
- Los resultados se ajustaron para múltiples factores de confusión, incluido el tabaquismo y la función pulmonar.
Conclusiones:
- El aumento de la hipersensibilidad de las vías respiratorias por histamina es un predictor de la mortalidad por EPOC.
- Esta relación predictiva se observó tanto en fumadores como en no fumadores.
- La hipersensibilidad de las vías respiratorias representa un factor crítico en la mortalidad relacionada con la EPOC.
Videos de Conceptos Relacionados
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...